The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
Synthesis and biological activity of vicinal diaryl-substituted 1H-imidazoles
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Room-Temperature Ionic Liquids: Solvents for Synthesis and Catalysis. 2
Hallett, J. P., & Welton, T. (2011) · Chemical Reviews · doi:10.1021/cr1003248 · Cited by 12,578
Room-Temperature Ionic Liquids. Solvents for Synthesis and Catalysis
Welton, T. (1999) · Chemical Reviews · doi:10.1021/cr980032t · Cited by 11,852
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Green Chemistry: Theory and Practice
Anastas, P. T., & Warner, J. C. (1998) · Medical Entomology and Zoology · Cited by 8,599
Comprehensive Heterocyclic Chemistry II
KATRITZKY, A. R., Rees, C. W., & Scriven, E. F. V. (1997) · Medical Entomology and Zoology · Cited by 8,499
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Ionic Liquids—New “Solutions” for Transition Metal Catalysis
Wasserscheid, P., & Keim, W. (2000) · Angewandte Chemie · doi:10.1002/1521-3773(20001103)39:21<3772::aid-anie3772>3.0.co;2-5 · Cited by 5,720
The Atom Economy—A Search for Synthetic Efficiency
Trost, B. (1991) · Science · doi:10.1126/science.1962206 · Cited by 4,798
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Recent Developments in Isocyanide Based Multicomponent Reactions in Applied Chemistry
Dömling, A. (2006) · Chemical Reviews · doi:10.1021/cr0505728 · Cited by 4,106
Multicomponent Reactions with Isocyanides
Dömling, A., & Ugi, I. (2000) · Angewandte Chemie · doi:10.1002/1521-3773(20000915)39:18<3168::aid-anie3168>3.0.co;2-u · Cited by 4,077
N-Heterocyclic Carbenes: A New Concept in Organometallic Catalysis
Herrmann, W. A. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020415)41:8<1290::aid-anie1290>3.0.co;2-y · Cited by 3,769
Bourissou, D., Guerret, O., Gabbaï, F. P., & Bertrand, G. (2000) · Chemical Reviews · doi:10.1021/cr940472u · Cited by 3,633
Moncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
1,3-Dipolar Cycloaddition Chemistry
Padwa, A. (1984) · Medical Entomology and Zoology · Cited by 3,241
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,701
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Atom Economy—A Challenge for Organic Synthesis: Homogeneous Catalysis Leads the Way
Trost, B. M. (1995) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199502591 · Cited by 2,603
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Origins, Current Status, and Future Challenges of Green Chemistry
Anastas, P. T., & Kirchhoff, M. M. (2002) · Accounts of Chemical Research · doi:10.1021/ar010065m · Cited by 2,214
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)00357-f · Cited by 2,086
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960803q · Cited by 1,965
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
On the Mechanism of Thiamine Action. IV.1 Evidence from Studies on Model Systems
Breslow, R. (1958) · Journal of the American Chemical Society · doi:10.1021/ja01547a064 · Cited by 1,721
Cobb, M. H., & Goldsmith, E. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.14843 · Cited by 1,719
Herrmann, W. A., & Köcher, C. (1997) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199721621 · Cited by 1,687
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
The p38 signal transduction pathway Activation and function
Ono, K., & Han, J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00071-6 · Cited by 1,571
Wu, G., Robertson, D. H., Brooks, C. L., & Vieth, M. (2003) · Journal of Computational Chemistry · doi:10.1002/jcc.10306 · Cited by 1,566
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470
Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
Kölch, W. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510289 · Cited by 1,441
Selective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,232
Dayer, J. M., Beutler, B., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.2163 · Cited by 1,216
Klapars, A., Antilla, J. C., Huang, X., & Buchwald, S. L. (2001) · Journal of the American Chemical Society · doi:10.1021/ja016226z · Cited by 1,021
A Critical Review on Chagas Disease Chemotherapy
Coura, J. R., & Castro, S. L. D. (2002) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762002000100001 · Cited by 1,003
Toxicity and antimicrobial activity of imidazolium and pyridinium ionic liquids
Docherty, K. M., & Kulpa, Jr. (2005) · Green Chemistry · doi:10.1039/b419172b · Cited by 990
Pharmacology of drugs that alter multidrug resistance in cancer.
Ford, J. M., & Hait, W. N. (1990) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00045-6 · Cited by 974
The Role of Interleukin-1 in Disease
Epstein, F. H., Dinarello, C. A., & Wolff, S. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280207 · Cited by 954
Disrupting tumour blood vessels
Tozer, G. M., Kanthou, C., & Baguley, B. C. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1628 · Cited by 930
Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry
Beale, J. M., & Block, J. H. (2011) · Andalas University Repository (Andalas University) · Cited by 914
Green chemistry: challenges and opportunities
Clark, J. H. (1999) · Green Chemistry · doi:10.1039/a807961g · Cited by 896
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865
Oxidative C−H Activation/C−C Bond Forming Reactions: Synthetic Scope and Mechanistic Insights
Kalyani, D., Deprez, N. R., Desai, L. V., & Sanford, M. S. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051402f · Cited by 796
Chen, Z., Gibson, T. B., Robinson, F., Silvestro, L., Pearson, G., Xu, B.-E., Wright, A., Vanderbilt, C., & Cobb, M. H. (2001) · Chemical Reviews · doi:10.1021/cr000241p · Cited by 788
Angiogenesis: regulators and clinical applications
Liekens, S., De Clercq, E., & Neyts, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00529-3 · Cited by 748
The Raf/MEK/ERK pathway: new concepts of activation
Peyssonnaux, C., & Eychène, A. (2001) · Biology of the Cell · doi:10.1016/s0248-4900(01)01125-x · Cited by 735
Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724
Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro
Dinarello, C. A., & Thompson, R. C. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90142-g · Cited by 724
Vane, J. (1994) · Nature · doi:10.1038/367215a0 · Cited by 699
Handbook of Green Chemistry and Technology
(2002) · Wiley eBooks · doi:10.1002/9780470988305 · Cited by 659
Cyclooxygenase 2: a molecular target for cancer prevention and treatment
Subbaramaiah, K., & Dannenberg, A. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00043-3 · Cited by 649
Laping, N. J., Grygielko, E., Mathur, A., Butter, S., Bomberger, J., Tweed, C., Martin, W., Fornwald, J., Lehr, R., Harling, J., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.58 · Cited by 635
Medicinal Chemistry of Combretastatin A4: Present and Future Directions
Tron, G. C., Pirali, T., Sorba, G., Pagliai, F., Busacca, S., & Genazzani, A. A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0512903 · Cited by 629
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.
Dark, G. G., Hill, S. A., Prise, V. E., Tozer, G. M., Pettit, G. R., & Chaplin, D. J. (1997) · PubMed · Cited by 622
Bellina, F., & Rossi, R. (2006) · Tetrahedron · doi:10.1016/j.tet.2006.05.024 · Cited by 606
Self-citationMulticomponent reactions in organic chemistry
Ugi, I., Dömling, A. S. S., & Hörl, W. (1994) · Endeavour · doi:10.1016/s0160-9327(05)80086-9 · Cited by 597
Highly Efficient and Mild Copper‐Catalyzed N‐ and C‐Arylations with Aryl Bromides and Iodides
Cristau, H., Cellier, P. P., Spindler, J., & Taillefer, M. (2004) · Chemistry – A European Journal · doi:10.1002/chem.200400582 · Cited by 586
Pyridinyl Imidazole Inhibitors of p38 Mitogen-activated Protein Kinase Bind in the ATP Site
Young, P. R., McLaughlin, M. M., Kumar, S., Kassis, S., Doyle, M. L., McNulty, D., Gallagher, T. F., Fisher, S., McDonnell, P. C., Carr, S. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12116 · Cited by 570
Mechanisms of TGF-β signaling in regulation of cell growth and differentiation
Moustakas, A., Pardali, K., Gaal, A., & Heldin, C.-H. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00023-8 · Cited by 541
Pharmacology of Cannabinoid Receptor Ligands
Pertwee, R. G. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401124036 · Cited by 526
Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism.
Suckling, K. E., & Stange, E. F. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34322-4 · Cited by 522
Role of Transforming Growth Factor-beta Signaling in Cancer
de Caestecker, M. P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.17.1388 · Cited by 522
Kumar, S., McDonnell, P. C., Gum, R. J., Hand, A. T., Lee, J. C., & Young, P. R. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6849 · Cited by 506
Pharmacology of Cannabinoid Receptors
Howlett, A. C. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003135 · Cited by 488
American Association for Cancer Research
Salgaller, M. L. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.6.1413 · Cited by 473
Kummer, J. L., Rao, P. K., & Heidenreich, K. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20490 · Cited by 468
Structure−Activity Relationships of Pyrazole Derivatives as Cannabinoid Receptor Antagonists
Lan, R., Liu, Q., Fan, P., Lin, S., Fernando, S. R., McCallion, D., Pertwee, R., & Makriyannis, A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980363y · Cited by 447
Efficient Synthesis of Imidazoles from Aldehydes and 1,2-Diketones Using Microwave Irradiation
Wolkenberg, S. E., Wisnoski, D. D., Leister, W. H., Wang, Y., Zhao, Z., & Lindsley, C. W. (2004) · Organic Letters · doi:10.1021/ol049682b · Cited by 432
Transcriptional regulation by MAP kinases
Davis, R. J. (1995) · Molecular Reproduction and Development · doi:10.1002/mrd.1080420414 · Cited by 429
Wang, L., Woods, K. W., Li, Q., Barr, K. J., McCroskey, R. W., Hannick, S. M., Gherke, L., Credo, R. B., Hui, Y.-H., Marsh, K. G., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010523x · Cited by 422
The endocannabinoid system as a target for therapeutic drugs
Piomelli, D., Giuffrida, A., Calignano, A., & Rodrı́guez de Fonseca, F. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01482-6 · Cited by 421
DaCosta Byfield, S., Major, C., Laping, N. J., & Roberts, A. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.744 · Cited by 414
Inhibitors of Cytochrome P-450s and Their Mechanism of Action
Testa, B., & Jenner, P. (1981) · Drug Metabolism Reviews · doi:10.3109/03602538109011082 · Cited by 397
Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6
Pettit, G. R., Singh, S. B., Boyd, M. R., Hamel, E., Pettit, R. K., Schmidt, J. M., & Hogan, F. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00010a011 · Cited by 396
Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).
Chang, F., Steelman, L. S., Shelton, J. G., Lee, J. T., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · PubMed · Cited by 392
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
Whittle, B. J. R., Higgs, G. A., Eakins, K. E., Moncada, S., & Vane, J. R. (1980) · Nature · doi:10.1038/284271a0 · Cited by 392
CANNABINOID RECEPTORS AND THEIR ENDOGENOUS AGONISTS
Felder, C. C., & Glass, M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.179 · Cited by 390
Cuenda, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.2.295 · Cited by 362
ACAT-2, A Second Mammalian Acyl-CoA:Cholesterol Acyltransferase
Cases, S., Novak, S., Zheng, Y.-W., Myers, H. M., Lear, S. R., Sande, E., Welch, C. B., Lusis, A. J., Spencer, T. A., Krause, B. R., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26755 · Cited by 344
The biology of the combretastatins as tumour vascular targeting agents
TOZER, G. M., KANTHOU, C., PARKINS, C. S., & HILL, S. A. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00211.x · Cited by 335
Muscarine, imidazole, oxazole and thiazole alkaloids
Jin, Z. (2016) · Natural Product Reports · doi:10.1039/c6np00067c · Cited by 329
Pettit, G. R., Singh, S. B., Niven, M. L., Hamel, E., & Schmidt, J. M. (1987) · Journal of Natural Products · doi:10.1021/np50049a016 · Cited by 328
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia
Kapur, S., & Remington, G. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.503 · Cited by 324
COX-2: A Target for Colon Cancer Prevention
Marnett, L. J., & DuBois, R. N. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082301.164620 · Cited by 313
Eyers, P. A., Craxton, M., Morricel, N., Cohen, P., & Goedert, M. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90170-3 · Cited by 310
Callahan, J. F., Burgess, J. L., Fornwald, J. A., Gaster, L. M., Harling, J. D., Harrington, F. P., Heer, J., Kwon, C., Lehr, R., Mathur, A., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010493y · Cited by 308
Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs
Xie, W., Robertson, D. L., & Simmons, D. L. (1992) · Drug Development Research · doi:10.1002/ddr.430250402 · Cited by 306
Anderson, R. A., Joyce, C., Davis, M., Reagan, J. W., Clark, M., Shelness, G. S., & Rudel, L. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26747 · Cited by 302
Multidrug Resistance Reversal Agents
Robert, J., & Jarry, C. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030183a · Cited by 292
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
Le Foll, B., & Goldberg, S. R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 291
Naturally Occurring and Synthetic Imidazoles: Their Chemistry and Their Biological Activities
Luca, L. (2006) · Current Medicinal Chemistry · doi:10.2174/0929867310607010001 · Cited by 279
Frasch, S. C., Nick, J. A., Fadok, V. A., Bratton, D. L., Worthen, G. S., & Henson, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8389 · Cited by 275
The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase
Wilson, K. P., McCaffrey, P. G., Hsiao, K., Pazhanisamy, S., Galullo, V., Bemis, G. W., Fitzgibbon, M. J., Caron, P. R., Murcko, M. A., & Su, M. S. S. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90194-0 · Cited by 274
Schwenger, P., Bellosta, P., Vietor, I., Basilico, C., Skolnik, E. Y., & Vilček, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2869 · Cited by 274
The Ras-Raf-MEK-ERK Pathway in the Treatment of Cancer
Hilger, R. A., Scheulen, M. E., & Strumberg, D. (2002) · Oncology Research and Treatment · doi:10.1159/000068621 · Cited by 265
Tubulin and microtubules as targets for anticancer drugs.
Hadfield, J. A., Ducki, S., Hirst, N., & McGown, A. T. (2003) · PubMed · Cited by 247
Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601
Zhang, B.-H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5429 · Cited by 245
Vincent, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24586 · Cited by 242
Haller, J., Varga, B., Ledent, C., & Freund, T. F. (2004) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000135704.56422.40 · Cited by 241
Imidazole and Benzimidazole Synthesis
(1997) · Elsevier eBooks · doi:10.1016/b978-0-12-303190-7.x5012-2 · Cited by 237
Cyclooxygenase-2 and prostate carcinogenesis
Hussain, T., Gupta, S., & Mukhtar, H. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00524-4 · Cited by 237
Trost, B. M., Toste, F. D., & Greenman, K. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0286573 · Cited by 237
Gans, K. R., Galbraith, W., Roman, R. J., Haber, S. B., Kerr, J. S., Schmidt, W. K., Smith, C., Hewes, W. E., & Ackerman, N. R. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12610-4 · Cited by 231
Clinical trials of agents that reverse multidrug resistance. A literature review
Raderer, M., & Scheithauer, W. (1993) · Cancer · doi:10.1002/1097-0142(19931215)72:12<3553::aid-cncr2820721203>3.0.co;2-b · Cited by 228
Green chemistry: an introductory text
(2011) · Choice Reviews Online · doi:10.5860/choice.48-2684 · Cited by 222
Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase
Gallagher, T. F., Seibel, G. L., Kassis, S., Laydon, J. T., Blumenthal, M. J., Lee, J. C., Lee, D., Boehm, J. C., Fier-Thompson, S. M., Abt, J. W., et al. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(96)00212-x · Cited by 219
Combretastatins: from natural products to drug discovery
Cirla, A., & Mann, J. (2003) · Natural Product Reports · doi:10.1039/b306797c · Cited by 218
Targeting tumour vasculature: the development of combretastatin A4
Griggs, J., Metcalfe, J. C., & Hesketh, R. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00224-2 · Cited by 207
Murry, J. A., Frantz, D. E., Soheili, A., Tillyer, R., Grabowski, E. J. J., & Reider, P. J. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0165943 · Cited by 200
Liverton, N. J., Butcher, J. W., Claiborne, C. F., Claremon, D. A., Libby, B. E., Nguyen, K. T., Pitzenberger, S. M., Selnick, H. G., Smith, G. R., Tebben, A., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9805236 · Cited by 196
New approaches in the treatment of type 2 diabetes
Zhang, B. B., & Moller, D. E. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00103-4 · Cited by 196
Atypical antipsychotic agents: A critical review
Worrel, J. A., Marken, P. A., Beckman, S. E., & Ruehter, V. L. (2000) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/57.3.238 · Cited by 194
Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents
Sliskovic, D. R., & White, A. D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90546-5 · Cited by 194
The identification of potent and selective imidazole-based inhibitors of B-Raf kinase
Takle, A. K., Brown, M. J. B., Davies, S., Dean, D. K., Francis, G., Gaiba, A., Hird, A. W., King, F. D., Lovell, P. J., Naylor, A., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.09.072 · Cited by 194
Combretastatin A4 phosphate: background and current clinical status
Young, S. L., & Chaplin, D. J. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.9.1171 · Cited by 192
Newman, M. J., Rodarte, J. C., Benbatoul, K. D., Romano, S. J., Zhang, C., Krane, S., Moran, E. J., Uyeda, R. T., Dixon, R., Guns, E. S. T., et al. (2000) · PubMed · Cited by 190
Ras—A Molecular Switch Involved in Tumor Formation
Wittinghofer, A., & Waldmann, H. (2000) · Angewandte Chemie · doi:10.1002/1521-3773(20001201)39:23<4192::aid-anie4192>3.0.co;2-y · Cited by 186
Ohsumi, K., Hatanaka, T., Fujita, K., Nakagawa, R., Fukuda, Y., Nihei, Y., Suga, Y., Morinaga, Y., Akiyama, Y., & Tsuji, T. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00579-4 · Cited by 185
TGF beta signalling and its role in tumour pathogenesis.
Kaminska, B., Wesolowska, A., & Danilkiewicz, M. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3446 · Cited by 185
Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity
Fitzgerald, C. E., Patel, S. B., Becker, J. W., Cameron, P. M., Zaller, D., Pikounis, V. B., O'Keefe, S. J., & Scapin, G. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb949 · Cited by 182
Lange, J. H. M., van Stuivenberg, H. H., Coolen, H. K. A. C., Adolfs, T. J. P., McCreary, A. C., Keizer, H. G., Wals, H. C., Veerman, W., Borst, A. J. M., de Looff, W., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040843r · Cited by 181
Antolini, M., Bozzoli, A., Ghiron, C., Kennedy, G., Rossi, T., & Ursini, A. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00112-2 · Cited by 179
Multiple intracellular MAP kinase signaling cascades
Bokemeyer, D., Sorokin, A., & Dunn, M. J. (1996) · Kidney International · doi:10.1038/ki.1996.172 · Cited by 173
1,2-Diarylpyrroles as Potent and Selective Inhibitors of Cyclooxygenase-2
Khanna, I. K., Weier, R. M., Yu, Y., Collins, P. W., Miyashiro, J. M., Koboldt, C. M., Veenhuizen, A. W., Currie, J. L., Seibert, K., & Isakson, P. C. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970036a · Cited by 171
Potent, orally absorbed glucagon receptor antagonists
de Laszlo, S. E., Hacker, C., Li, B., Kim, D., MacCoss, M., Mantlo, N., Pivnichny, J. V., Colwell, L., Koch, G. E., Cascieri, M. A., et al. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00081-5 · Cited by 169
A historical perspective of clozapine.
Hippius, H. (1999) · PubMed · Cited by 166
Wanted: new multicomponent reactions for generating libraries of polycyclic natural products
Ulaczyk-Lesanko, A., & Hall, D. G. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.04.003 · Cited by 166
Green chemistry: an introductory text
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6427 · Cited by 166
Khanna, I., Weier, R. M., Yu, Y., Xu, X. D., Koszyk, F. J., Collins, P. W., Koboldt, C. M., Veenhuizen, A. W., Perkins, W. E., Casler, J. J., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9700225 · Cited by 165
RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase
Wadsworth, S. A., CAVENDER, D. E., Beers, S. A., Lalan, P., Schafer, P. H., Malloy, E. A., Wu, W., Fahmy, B., Olini, G. C., Davis, J. E., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35155-9 · Cited by 157
An efficient conversion of nitriles to amidines
Garigipati, R. S. (1990) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)88891-7 · Cited by 154
ACAT inhibitors as antiatherosclerotic agents: Compounds and mechanisms
Matsuda, K. (1994) · Medicinal Research Reviews · doi:10.1002/med.2610140302 · Cited by 152
Simoni, D., Grisolia, G., Giannini, G., Roberti, M., Rondanin, R., Piccagli, L., Baruchello, R., Rossi, M., Romagnoli, R., Invidiata, F. P., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049622b · Cited by 149
Krause, B., Anderson, M., Bisgaier, C. L., et al. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40755-2 · Cited by 148
Lan, J., Chen, L., Yu, X., You, J., & Xie, R. (2004) · Chemical Communications · doi:10.1039/b307734a · Cited by 147
COX inhibitors and breast cancer
Mazhar, D., Ang, R., & Waxman, J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602942 · Cited by 146
Vascular disrupting agents: a new class of drug in cancer therapy
Gaya, A. M., & Rustin, G. J. S. (2005) · Clinical Oncology · doi:10.1016/j.clon.2004.11.011 · Cited by 145
Almansa, C., Alfon, J. A., de Arriba, A. F., Cavalcanti, F. L., Escamilla, I., Gómez, L. A., Miralles, A., Soliva, R., Bartrolí, J., Carceller, E., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030765s · Cited by 142
Matsuyama, S., Iwadate, M., Kondo, M., Saitoh, M., Hanyu, A., Shimizu, K., Aburatani, H., Mishima, H. K., Imamura, T., Miyazono, K., et al. (2003) · PubMed · Cited by 142
Santo, R. D., Tafi, A., Costi, R., Botta, M., Artico, M., Corelli, F., Forte, M., Caporuscio, F., Angiolella, L., & Palamara, A. T. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm048997u · Cited by 140
2,4,5- triarylimidazole inhibitors of IL-1 biosynthesis
Gallagher, T. F., Fier-Thompson, S. M., Garigipati, R. S., Sorenson, M. E., Smietana, J. M., Lee, D. M., Bender, P. E., Lee, J. C., Laydon, J. T., Griswold, D. E., et al. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00189-z · Cited by 133
Sayama, K., Hanakawa, Y., Shirakata, Y., Yamasaki, K., Sawada, Y., Sun, L., Yamanishi, K., Ichijo, H., & Hashimoto, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003425200 · Cited by 131
Vinod, K. Y., Arango, V., Xie, S., Kassir, S. A., Mann, J. J., Cooper, T. B., & Hungund, B. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.033 · Cited by 127
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt.
Majewski, M., Nieborowska-Skorska, M., Salomoni, P., Słupianek, A., Reiss, K., Trotta, R., Calabretta, B., & Skórski, T. (1999) · PubMed · Cited by 126
Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.
Borowski, E., Bontemps‐Gracz, M. M., & Piwkowska, A. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3421 · Cited by 124
Hori, K., & Saito, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601261 · Cited by 123
Boehm, J. C., Smietana, J. M., Sorenson, M. E., Garigipati, R. S., Gallagher, T. F., Sheldrake, P. W., Bradbeer, J. N., Badger, A. M., Laydon, J. T., Lee, J. C., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960415o · Cited by 123
Khanna, I., Yu, Y., Huff, R. M., Weier, R. M., Xu, X.-D., Koszyk, F. J., Collins, P. W., Cogburn, J. N., Isakson, P. C., Koboldt, C. M., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0000719 · Cited by 122
Pyrroles and other heterocycles as inhibitors of P38 kinase
de Laszlo, S. E., Visco, D. M., Agarwal, L., Chang, L. L., Chin, J., Croft, G. F., Forsyth, A., Fletcher, D. S., Frantz, B., Hacker, C., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00495-8 · Cited by 121
Promoting sustainability through green chemistry
Kirchhoff, M. M. (2005) · Resources Conservation and Recycling · doi:10.1016/j.resconrec.2005.01.003 · Cited by 118
Small molecular anti-cytokine agents
Wagner, G. K., & Laufer, S. (2005) · Medicinal Research Reviews · doi:10.1002/med.20042 · Cited by 117
Synthesis and Cytotoxic Evaluation of Combretafurazans
Tron, G. C., Pagliai, F., Grosso, E. D., Genazzani, A. A., & Sorba, G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049096o · Cited by 117
Salomoni, P., Wasik, M. A., Riedel, R. F., Reiss, K., Choi, J. K., Skórski, T., & Calabretta, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.1995 · Cited by 116
Adams, J. L., Boehm, J. C., Kassis, S., Gorycki, P. D., Webb, E. F., Hall, R., Sorenson, M. E., Lee, J. C., Ayrton, A. D., Griswold, D. E., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00549-6 · Cited by 114
Fijen, J. W., Zijlstra, J. G., Boer, P. D., Spanjersberg, R., Tervaert, J.-W. C., van der Werf, T. S., Ligtenberg, J. J. M., & Tulleken, J. E. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01485.x · Cited by 113
Inhibition of TGFβ signaling in cancer therapy
Arteaga, C. L. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.009 · Cited by 111
Substituted Imidazoles as Glucagon Receptor Antagonists
Chang, L. L., Sidler, K. L., Cascieri, M. A., de Laszlo, S. E., Koch, G. E., Li, B., MacCoss, M., Mantlo, N. B., O’Keefe, S. J., Pang, M., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00498-x · Cited by 109
Adams, J. L., Boehm, J. C., Gallagher, T. F., Kassis, S., Webb, E. F., Hall, R., Sorenson, M. E., Garigipati, R. S., Griswold, D. E., & Lee, J. C. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00570-4 · Cited by 107
New method for direct conversion of amides to amines
Radhakrishna, A. S., Parham, M. E., Riggs, R. M., & LOUDON, G. M. (1979) · The Journal of Organic Chemistry · doi:10.1021/jo01324a048 · Cited by 106
Lastres‐Becker, I., Berrendero, F., Lucas, J. J., Martı́n-Aparicio, E., Yamamoto, A., Ramos, J. A., & Fernández‐Ruíz, J. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03403-5 · Cited by 103
Antifungal Imidazoles Block Assembly of Inducible NO Synthase into an Active Dimer
Sennequier, N., Wolan, D. W., & Stuehr, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.930 · Cited by 97
Chapter 21. Selective Cyclooxygenase-2 Inhibitors
Prasit, P., & Riendeau, D. (1997) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61479-7 · Cited by 96
Piek, E., & Roberts, A. B. (2001) · Advances in cancer research · doi:10.1016/s0065-230x(01)83001-3 · Cited by 94
Lee, H. T., Sliskovic, D. R., Picard, J. A., Roth, B. D., Wierenga, W., Hicks, J. L., Bousley, R. F., Hamelehle, K. L., Homan, R., Speyer, C. L., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960674d · Cited by 94
Madsen, P., Knudsen, L. B., Wiberg, F. C., & Carr, R. D. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9810304 · Cited by 92
Targeted Agents for the Treatment of Advanced Renal Cell Carcinoma
Staehler, M. D., Rohrmann, K., Haseke, N., Stief, C. G., & Siebels, M. (2005) · Current Drug Targets · doi:10.2174/138945005774574498 · Cited by 90
The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs
Wallace, J. L., & Cirino, G. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90083-3 · Cited by 88
Raf‐1 is activated by the p38 mitogen‐activated protein kinase inhibitor, SB203580
Kalmes, A., Deou, J., Clowes, A. W., & Daum, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00034-4 · Cited by 86
McLay, I. M., Halley, F., Souness, J. E., McKenna, J. M., Benning, V., Birrell, M. A., Burton, B., Belvisi, M. G., Collis, A. J., Constan, A. A., et al. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00331-x · Cited by 86
Fu, S.-L., Wu, Y.-L., Zhang, Y.-P., Qiao, M.-M., & Chen, Y. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i13.1971 · Cited by 86
Cannabinoid receptor antagonists and obesity.
Black, S. C. (2004) · PubMed · Cited by 85
Synthesis and Cytotoxicity of 3,4-Diaryl-2(5H)-furanones
Kim, Y. D., Nam, N., You, Y., & Ahn, B. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00831-9 · Cited by 84
Lisnock, J., Griffin, P., Calaycay, J., Frantz, B., Parsons, J., O'Keefe, S. J., & LoGrasso, P. (2000) · Biochemistry · doi:10.1021/bi992410+ · Cited by 79
Promoting Green Engineering through Green Chemistry
Kirchhoff, M. M. (2003) · Environmental Science & Technology · doi:10.1021/es0346072 · Cited by 79
Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
Reggio, P. H. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454577 · Cited by 78
The Development of Cannabinoid Antagonists
Barth, F., & Rinaldi, M. L. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401143808 · Cited by 77
Cannabinoids reduce symptoms of Tourette?s syndrome
Müller‐Vahl, K. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.10.1717 · Cited by 75
The Role of Interleukin-1 in Disease
(1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281025 · Cited by 74
Multidrug resistance in oncology: diagnostic and therapeutic approaches
Robert, J. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00495.x · Cited by 72
Cameron, P. M., Limjuco, G. A., Chin, J., Silberstein, L. E., & Schmidt, J. A. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.1.237 · Cited by 72
Cannabinoid Receptors as Therapeutic Targets
Makriyannis, A., Nikas, S. P., Thakur, G. A., & Pavlopoulos, S. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776873743 · Cited by 69
Combretoxazolones: synthesis, cytotoxicity and antitumor activity
Nam, N., Kim, Y., You, Y., Hong, D.-H., Kim, H.-M., & Ahn, B. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00622-9 · Cited by 66
Lantos, I., Bender, P. E., Razgaitis, K. A., Sutton, B. M., DiMartino, M. J., Griswold, D. E., & Walz, D. T. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00367a014 · Cited by 66
Abrogation of c-Raf expression induces apoptosis in tumor cells
Lau, Q. C., Brüsselbach, S., & Müller, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201709 · Cited by 65
Glucagon as a target for the treatment of Type 2 diabetes
Sloop, K. W., Michael, M. D., & Moyers, J. S. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.593 · Cited by 64
Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318
Chen, L., Liang, Y.-J., Ruan, J., Ding, Y. P., Wang, X., Shi, Z., Gu, L., Yang, X.-P., & Fu, L. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357043879 · Cited by 61
Jacobs, C., Frotscher, M., Dannhardt, G., & Hartmann, R. W. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm991180u · Cited by 61
Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis
Révész, L., Blum, E., Padova, F. E. D., Buhl, T., Feifel, R., Gram, H., HIESTAND, P. C., Manning, U., & Rucklin, G. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.106 · Cited by 60
Chang, C. C. Y., Dong, R., Miyazaki, A., Sakashita, N., Zhang, Y., Liu, J., Guo, M., Li, B.-L., & Chang, T. (2006) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2006.00154.x · Cited by 57
Duffy, J. L., Kirk, B. A., Konteatis, Z. D., Campbell, E. L., Liang, R., Brady, E. J., Candelore, M. R., Ding, V. D. H., Jiang, G., Liu, F., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.003 · Cited by 57
Graczyk, P. P., Khan, A., Bhatia, G. S., Palmer, V. H., Medland, D., Numata, H., Oinuma, H., Catchick, J., Dunne, A., Ellis, M. V., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.076 · Cited by 56
Desiraju, G. R., Gopalakrishnan, B., Jetti, R. K. R., Nagaraju, A., Raveendra, D., Sarma, J. A. R. P., Sobhia, M. E., & Thilagavathi, R. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020198t · Cited by 56
de Dios, A., Shih, C., de Uralde, B. L., Sánchez, C., Prado, M. D., Cabrejas, L. M. M., Pleite, S., Blanco‐Urgoiti, J., Lorite, M. J., Nevill, C. R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm048978k · Cited by 55
Tempest, P. A. (2005) · PubMed · Cited by 55
Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.
Stip, É. (2000) · PubMed · Cited by 53
Acquisition of Inhibitor-Sensitive Protein Kinases through Protein Design
Bishop, A. C., & Shokat, K. M. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00060-6 · Cited by 51
Cited by
Singh, M. S., & Chowdhury, S. (2012) · RSC Advances · doi:10.1039/c2ra01056a · Cited by 506
Multicomponent syntheses of functional chromophores
Levi, L., & Müller, T. J. J. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00805k · Cited by 289
Fang, B., Zhou, C.-H., & Rao, X.-C. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.06.012 · Cited by 125
Metadata
- Authors
- Bellina, F., Cauteruccio, S., & Rossi, R.
- Venue
- Tetrahedron
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 63
- Issue
- 22
- Pages
- 4571-4624
- ISSN
- 0040-4020 (ISSN-L)
- OpenAlex
- W2056297591
- Cited by
- 254
- References
- 217
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.